PANACEA LIFE SCIENCES HOLDINGS, INC. Annual Cost of Revenue in USD from 2018 to 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate cost of goods produced and sold and services rendered during the reporting period.
Summary
Panacea Life Sciences Holdings, Inc. quarterly/annual Cost of Revenue history and growth rate from 2018 to 2023.
  • Panacea Life Sciences Holdings, Inc. Cost of Revenue for the quarter ending March 31, 2024 was $390K, a 13.6% decline year-over-year.
  • Panacea Life Sciences Holdings, Inc. Cost of Revenue for the twelve months ending March 31, 2024 was $1.2M, a 8.73% decline year-over-year.
  • Panacea Life Sciences Holdings, Inc. annual Cost of Revenue for 2023 was $1.26M, a 2.64% increase from 2022.
  • Panacea Life Sciences Holdings, Inc. annual Cost of Revenue for 2022 was $1.23M, a 19% decline from 2021.
  • Panacea Life Sciences Holdings, Inc. annual Cost of Revenue for 2021 was $1.52M, a 78.4% decline from 2020.
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Annual (USD)
Cost of Revenue, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $1.26M +$32.5K +2.64% Jan 1, 2023 Dec 31, 2023 10-K 2024-04-01
2022 $1.23M -$289K -19% Jan 1, 2022 Dec 31, 2022 10-K 2024-04-01
2021 $1.52M -$5.5M -78.4% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-30
2020 $7.02M +$5.08M +262% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-31
2019 $1.94M +$1.94M Jan 1, 2019 Dec 31, 2019 10-K/A 2021-04-23
2018 $0 Jan 1, 2018 Dec 31, 2018 10-K 2020-05-22
* An asterisk sign (*) next to the value indicates that the value is likely invalid.